Physician profile
Daniel T Ocarroll
NPI 1437142858
$3,597.97
in general payments reported to CMS, 2019-2025
19 companies · $802 in 2025
The $802 reported for 2025 was more than what 84% of Sports Medicine (Podiatrist) providers received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.80 · 2020: $26.28 · 2021: $93.36 · 2022: $809 · 2023: $1,154 · 2024: $652 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,355.35 | 2021-2025 | Puraply, Cygnus Dual, Affinity |
| Smith+Nephew, INC. | $210.37 | 2022-2024 | Versajet, Grafix Pl, Oasis |
| Stryker Corporation | $177.67 | 2021-2025 | Ortholoc 3di |
| Integra Lifesciences Corporation | $168.50 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $100.38 | 2024-2025 | Exparel |
| Depuy Synthes Sales INC. | $90.91 | 2025 | Quickanchor Orthocord, Na |
| Paragon 28, INC. | $90.14 | 2024-2025 | Total Talus, Monster |
| Sebela Pharmaceuticals INC. | $70.15 | 2020-2022 | |
| Flower Orthopedics Coporation | $50.67 | 2025 | |
| Paratek Pharmaceuticals, INC. | $49.97 | 2024-2025 | Nuzyra |
| Fusion Orthopedics USA, LLC | $46.89 | 2023-2025 | |
| Fidia Pharma USA INC. | $39.35 | 2019-2020 | |
| Treace Medical Concepts, INC. | $35.17 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $33.36 | 2025 | |
| Linvatec Corporation | $17.36 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $16.68 | 2025 | |
| Orthofix Medical, INC. | $15.14 | 2022 | |
| Glenmark Therapeutics INC. | $15.00 | 2019 | |
| Djo, LLC | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ocarroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.